285 related articles for article (PubMed ID: 36140378)
1. Synuclein Proteins in MPTP-Induced Death of Substantia Nigra Pars Compacta Dopaminergic Neurons.
Goloborshcheva VV; Kucheryanu VG; Voronina NA; Teterina EV; Ustyugov AA; Morozov SG
Biomedicines; 2022 Sep; 10(9):. PubMed ID: 36140378
[TBL] [Abstract][Full Text] [Related]
2. β-synuclein potentiates synaptic vesicle dopamine uptake and rescues dopaminergic neurons from MPTP-induced death in the absence of other synucleins.
Ninkina N; Millership SJ; Peters OM; Connor-Robson N; Chaprov K; Kopylov AT; Montoya A; Kramer H; Withers DJ; Buchman VL
J Biol Chem; 2021 Dec; 297(6):101375. PubMed ID: 34736896
[TBL] [Abstract][Full Text] [Related]
3. Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of gamma-synuclein, alpha-synuclein and double alpha/gamma-synuclein null mutant mice.
Robertson DC; Schmidt O; Ninkina N; Jones PA; Sharkey J; Buchman VL
J Neurochem; 2004 Jun; 89(5):1126-36. PubMed ID: 15147505
[TBL] [Abstract][Full Text] [Related]
4. Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP.
Vila M; Vukosavic S; Jackson-Lewis V; Neystat M; Jakowec M; Przedborski S
J Neurochem; 2000 Feb; 74(2):721-9. PubMed ID: 10646524
[TBL] [Abstract][Full Text] [Related]
5. Genetic reduction of mitochondrial complex I function does not lead to loss of dopamine neurons in vivo.
Kim HW; Choi WS; Sorscher N; Park HJ; Tronche F; Palmiter RD; Xia Z
Neurobiol Aging; 2015 Sep; 36(9):2617-27. PubMed ID: 26070241
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Parkinson's disease-associated alpha-synucleinA53T by recombinant adeno-associated virus in mice does not increase the vulnerability of dopaminergic neurons to MPTP.
Dong Z; Ferger B; Feldon J; Büeler H
J Neurobiol; 2002 Oct; 53(1):1-10. PubMed ID: 12360578
[TBL] [Abstract][Full Text] [Related]
7. Dose-related biphasic effect of the Parkinson's disease neurotoxin MPTP, on the spread, accumulation, and toxicity of α-synuclein.
Merghani MM; Ardah MT; Al Shamsi M; Kitada T; Haque ME
Neurotoxicology; 2021 May; 84():41-52. PubMed ID: 33549656
[TBL] [Abstract][Full Text] [Related]
8. Role of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice.
Schlüter OM; Fornai F; Alessandrí MG; Takamori S; Geppert M; Jahn R; Südhof TC
Neuroscience; 2003; 118(4):985-1002. PubMed ID: 12732244
[TBL] [Abstract][Full Text] [Related]
9. α-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism.
Yun SP; Kim D; Kim S; Kim S; Karuppagounder SS; Kwon SH; Lee S; Kam TI; Lee S; Ham S; Park JH; Dawson VL; Dawson TM; Lee Y; Ko HS
Mol Neurodegener; 2018 Jan; 13(1):1. PubMed ID: 29310663
[TBL] [Abstract][Full Text] [Related]
10. Iron and alpha-synuclein in the substantia nigra of MPTP-treated mice: effect of neuroprotective drugs R-apomorphine and green tea polyphenol (-)-epigallocatechin-3-gallate.
Mandel S; Maor G; Youdim MB
J Mol Neurosci; 2004; 24(3):401-16. PubMed ID: 15655262
[TBL] [Abstract][Full Text] [Related]
11. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.
Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG
Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254
[TBL] [Abstract][Full Text] [Related]
12. TLR4 deficiency has a protective effect in the MPTP/probenecid mouse model of Parkinson's disease.
Shao QH; Chen Y; Li FF; Wang S; Zhang XL; Yuan YH; Chen NH
Acta Pharmacol Sin; 2019 Dec; 40(12):1503-1512. PubMed ID: 31388087
[TBL] [Abstract][Full Text] [Related]
13. Increased Expression of Alpha-, Beta-, and Gamma-Synucleins in Brainstem Regions of a Non-Human Primate Model of Parkinson's Disease.
Duperrier S; Bortolozzi A; Sgambato V
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955716
[TBL] [Abstract][Full Text] [Related]
14. The mouse MPTP model: gene expression changes in dopaminergic neurons.
Kühn K; Wellen J; Link N; Maskri L; Lübbert H; Stichel CC
Eur J Neurosci; 2003 Jan; 17(1):1-12. PubMed ID: 12534964
[TBL] [Abstract][Full Text] [Related]
15. [Comparative Analysis of MPTP Neurotoxicity in Mice with a Constitutive Knockout of the α-Synuclein Gene].
Chaprov KD; Teterina EV; Roman AY; Ivanova TA; Goloborshcheva VV; Kucheryanu VG; Morozov SG; Lysikova EA; Lytkina OA; Koroleva IV; Popova NI; Antohin AI; Ovchinnikov RK; Kukharsky MS
Mol Biol (Mosk); 2021; 55(1):152-163. PubMed ID: 33566034
[TBL] [Abstract][Full Text] [Related]
16. Nitrated alpha-synuclein induces the loss of dopaminergic neurons in the substantia nigra of rats.
Yu Z; Xu X; Xiang Z; Zhou J; Zhang Z; Hu C; He C
PLoS One; 2010 Apr; 5(4):e9956. PubMed ID: 20386702
[TBL] [Abstract][Full Text] [Related]
17. Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration.
Drolet RE; Behrouz B; Lookingland KJ; Goudreau JL
Neurotoxicology; 2004 Sep; 25(5):761-9. PubMed ID: 15288507
[TBL] [Abstract][Full Text] [Related]
18. What have we learnt from CDNA microarray gene expression studies about the role of iron in MPTP induced neurodegeneration and Parkinson's disease?
Youdim MB
J Neural Transm Suppl; 2003; (65):73-88. PubMed ID: 12946050
[TBL] [Abstract][Full Text] [Related]
19. MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons.
Kowall NW; Hantraye P; Brouillet E; Beal MF; McKee AC; Ferrante RJ
Neuroreport; 2000 Jan; 11(1):211-3. PubMed ID: 10683860
[TBL] [Abstract][Full Text] [Related]
20. Dopaminergic neuron-specific deletion of p53 gene is neuroprotective in an experimental Parkinson's disease model.
Qi X; Davis B; Chiang YH; Filichia E; Barnett A; Greig NH; Hoffer B; Luo Y
J Neurochem; 2016 Sep; 138(5):746-57. PubMed ID: 27317935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
